经口内镜咽喉手术治疗浅表性下咽癌的临床总结
本研究回顾了258例浅表性下咽癌患者接受经口内镜咽喉手术(ELPS)的结果,中位随访31个月,3年总生存率85.7%,病因特异性生存率100%,仅3例局部复发经再次ELPS成功挽救,无患者出现声带麻痹,所有患者均可维持术前进食水平,提示ELPS是一种可行的微创治疗。
要点
- ELPS治疗浅表性下咽癌3年总生存率85.7%,病因特异性生存率100%。
- 局部复发率低,仅3例复发且均经再次ELPS成功挽救。
- 术后无患者出现声带麻痹,所有患者可维持术前进食水平。
核心结论
- ELPS是治疗浅表性下咽癌可行且微创的方法,生活质量结果良好。
主要发现
- 258例患者中位随访31个月,3年总生存率85.7%,病因特异性生存率100%。
- 仅3例出现局部复发,均经再次ELPS成功挽救。
- 4例因术后出血需再次手术。
- 无患者出现声带麻痹,所有患者均可维持术前进食水平。
临床怎么用
- 对于浅表性下咽癌,ELPS可作为兼顾肿瘤控制与生活质量的微创治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endoscopic laryngopharyngeal surgery (ELPS) was developed for superficial pharyngeal cancers in Japan. In this study, we present our results of ELPS for superficial pharyngeal cancers. METHODS: From November 2009 to December 2015, 258 patients with superficial pharyngeal cancers underwent ELPS. Results, including survival rates, postoperative complications, and vocal function, are reviewed. RESULTS: The median follow-up period of 258 patients was 31 months. The overall and cause-specific survival rates over 3 years were 85.7% and 100%, respectively. Only 3 patients incurred local recurrences and were successfully salvaged by re-ELPS. Regarding postoperative complications, 4 patients required reoperation because of postoperative bleeding. As for the postoperative quality of life, no patients developed vocal fold paralysis. Every patient was able to consume meals at preoperative levels. CONCLUSION: ELPS is a feasible and minimally invasive treatment for superficial pharyngeal cancers with impressive quality of life results.
引用
- Watanabe A, Taniguchi M, Kimura Y, et al. Synopsis of transoral endoscopic laryngopharyngeal surgery for superficial pharyngeal cancers. Head Neck. 2017. PMID: 28661556. doi:10.1002/hed.24839
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。